{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"submitter":["Yazdany J"],"funding":["NCRR NIH HHS","AHRQ HHS","NIAMS NIH HHS"],"pagination":["1170-7"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC3149719"],"repository":["biostudies-literature"],"omics_type":["Unknown"],"volume":["63(8)"],"pubmed_abstract":["<h4>Objective</h4>To develop and test the Brief Index of Lupus Damage (BILD), an interviewer-administered measure of damage in systemic lupus erythematosus (SLE), for use in epidemiologic studies in which administration of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index (SDI) by trained physicians is not possible or feasible. In addition, we compared the BILD to another recently developed patient-reported measure, the Lupus Damage Index Questionnaire (LDIQ), which was designed as a written survey.<h4>Methods</h4>A sample of 81 patients from 2 university-affiliated SLE clinics was used to test the criterion validity of the BILD and the LDIQ. A second sample, the Lupus Outcomes Study (n = 728), was used to ascertain the construct validity "],"journal":["Arthritis care & research"],"pubmed_title":["Brief index of lupus damage: a patient-reported measure of damage in systemic lupus erythematosus."],"pmcid":["PMC3149719"],"funding_grant_id":["P60 AR053308-04","5R01-AR56476","5-M01-RR-00079","2-R01-HS013893","K23 AR060259","R01 HS013893","M01 RR000079","R01 AR056476","R01 AR056476-06","P60 AR053308","P60-AR-053308"],"pubmed_authors":["Yazdany J","Katz PP","Trupin L","Gansky SA","Criswell LA","Dall'era M","Yelin EH"],"additional_accession":[]},"is_claimable":false,"name":"Brief index of lupus damage: a patient-reported measure of damage in systemic lupus erythematosus.","description":"<h4>Objective</h4>To develop and test the Brief Index of Lupus Damage (BILD), an interviewer-administered measure of damage in systemic lupus erythematosus (SLE), for use in epidemiologic studies in which administration of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index (SDI) by trained physicians is not possible or feasible. In addition, we compared the BILD to another recently developed patient-reported measure, the Lupus Damage Index Questionnaire (LDIQ), which was designed as a written survey.<h4>Methods</h4>A sample of 81 patients from 2 university-affiliated SLE clinics was used to test the criterion validity of the BILD and the LDIQ. A second sample, the Lupus Outcomes Study (n = 728), was used to ascertain the construct validity ","dates":{"release":"2011-01-01T00:00:00Z","publication":"2011 Aug","modification":"2025-04-21T13:43:12.876Z","creation":"2019-03-27T03:07:42Z"},"accession":"S-EPMC3149719","cross_references":{"pubmed":["21584946"],"doi":["10.1002/acr.20503"]}}